Lilly Reports Fourth-Quarter and Full-Year 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Eli Lilly (LLY) PT Raised to $85 at Barclays
February 1, 2017 7:58 AM ESTBarclays raised its price target on Eli Lilly (NYSE: LLY) to $85.00 (from $80.00) while maintaining a Overweight rating.
... MoreEli Lilly & Co. (LLY) Misses Q4 EPS by 2c, Sales Beat
January 31, 2017 6:26 AM ESTEli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $0.95, $0.02 worse than the analyst estimate of $0.97. Revenue for the quarter came in at $5.76 billion versus the consensus estimate of $5.55 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2017 EPS of $4.05-$4.15, versus the consensus of... More
